3686
K. Skonieczny et al.
PAPER
Anal. Calcd for C15H22O3: C, 71.97; H, 8.86. Found: C, 71.75; H,
8.90.
4-Formyl-2-hexyl-3-hydroxy-6H-dibenzo[b,d]pyran-6-one (14)
Following the general procedure, benzo[c]coumarin 10 (0.53 g, 1.8
mmol) was treated with HMTA (0.70 g, 5.0 mmol) in TFA (10 mL).
CH2Cl2 (10 mL) was added to the crude reaction mixture and phases
were separated. The aqueous phase was extracted with CH2Cl2 (10
mL) and the organic layers were combined, and dried (Na2SO4).
Drying agent was filtered, and the supernatant was evaporated with
silica gel (10 g). Chromatography (SiO2, CH2Cl2) afforded 14 as a
colorless solid; yield: 204 mg (35%); Rf = 0.58 (CH2Cl2); mp 115–
117 °C.
1H NMR (500 MHz, CDCl3): δ = 0.92 (t, J = 7.1 Hz, 3 H), 1.36 (m,
4 H), 1.43 (m, 2 H), 1.69 (quint, J = 7.3 Hz, 2 H), 2.74 (t, J = 7.8 Hz,
2 H), 7.57 (dt, J = 7.8, 1.0 Hz, 1 H), 7.86 (dt, J = 8.1, 1.4 Hz, 1 H),
8.02 (m, 2 H), 8.39 (dd, J = 8.0, 1.4 Hz, 1 H), 10.67 (s, 1 H), 12.47
(s, 1 H).
20
Yield: 0.27 g (27%); white crystalline solid; mp 109–110 °C.
1H NMR (500 MHz, CDCl3): δ = 1.40 (s, 9 H), 7.59 (s, 1 H), 9.70
(s, 1 H), 10.40 (s, 1 H), 12.39 (s, 1 H), 13.50 (s, 1 H).
13C NMR (125 MHz, CDCl3): δ = 29.2, 34.3, 109.1, 112.4, 130.6,
138.3, 165.7, 169.2, 194.0, 194.7.
HRMS (ESI): m/z calcd for C12H13O4 [M – H]–: 221.0814; found:
221.0815.
Anal. Calcd for C12H13O4: C, 64.85; H, 6.35. Found: C, 64.72; H,
6.40.
5,7-Diformyl-8-hydroxyquinoline 1-Oxide (21)
13C NMR (125 MHz, CDCl3): δ = 14.1, 22.6, 29.1, 29.3, 29.4, 31.7,
108.6, 108.7, 119.7, 121.0, 128.2, 128.5, 130.6, 130.8, 134.5, 135.3,
151.4, 159.9, 162.6, 193.8.
HRMS (ESI): m/z calcd for C20H20O4 + Na [M + Na]+: 347.1254,
found: 347.1253.
Following the general procedure, 8-hydroxyquinoline 1-oxide (7;
1.00 g, 6.2 mmol) was treated with HMTA (2.25 g, 16.1 mmol) in
TFA (7 mL). The precipitated crystals were filtered, washed with
H2O (40 mL), and recrystallized from EtOH to afford 21 as a yellow
crystalline solid; yield: 0.79 g (59%); mp 205–206 °C (EtOH).
1H NMR (500 MHz, DMSO-d6): δ = 7.95 (dd, J = 8.5, 6.5 Hz, 1 H),
8.46 (s, 1 H), 8.87 (dd, J = 6.0, 1.0 Hz, 1 H), 9.40 (dd, J = 9.0, 1.0
Hz, 1 H), 10.11 (s, 1 H), 10.43 (s, 1 H), 19.63 (s, 1 H).
13C NMR (125 MHz, DMSO-d6): δ = 118.7, 119.5, 127.1, 129.2,
129.4, 132.3, 136.9, 138.4, 165.8, 186.8, 192.0.
HRMS (EI): m/z calcd for C11H7NO4 [M+•]: 217.0375; found:
217.0371.
Ethyl 4-Formyl-3-hydroxypyrido[1,2-a]indole-10-carboxylate
(15)
Following the general procedure, ethyl 3-hydroxypyrido[1,2-a]in-
dole-10-carboxylate (11; 1.00 g, 3.9 mmol) was treated with HMTA
(1.42 g, 10.1 mmol) in TFA (10 mL). The solid obtained was puri-
fied by column chromatography on silica gel using toluene and
toluene–acetone (99:1) as eluent; yield: 0.2 g (18%); orange crystal-
line solid; mp 172–173 °C.
Anal. Calcd for C11H7NO4: C, 60.83; H, 3.25; N, 6.45. Found: C,
60.68; H, 3.08; N, 6.49.
1H NMR (500 MHz, CDCl3): δ = 1.49 (t, J = 7.0 Hz, 3 H), 4.46 (q,
J = 7.1 Hz, 2 H), 6.77–6.81 (m, 1 H), 7.07 (d, J = 9.1 Hz, 1 H), 7.14–
7.19 (m, 1 H), 8.35 (d, J = 7.3 Hz, 1 H), 8.40 (dd, J = 9.4, 1.1 Hz, 1
H), 8.60 (d, J = 9.0 Hz, 1 H), 10.84 (s, 1 H), 12.49 (s, 1 H).
13C NMR (125 MHz, CDCl3): δ = 14.6, 59.8, 97.1, 108.7, 112.9,
116.8, 121.4, 122.2, 124.8, 127.0, 127.4, 133.0, 139.9, 162.1, 164.9,
189.8.
5-Hydroxy-2,3-diphenylbenzofuran-4,7-dicarbaldehyde (22)
Following the general procedure, 2,3-diphenylbenzofuran-5-ol (8;
1.00 g, 3.5 mmol) was treated with HMTA (1.26 g, 9.0 mmol) in
TFA (7 mL). The solid obtained was purified by column chroma-
tography on silica gel using CH2Cl2 and CH2Cl2–MeOH (99:1) as
eluent; yield: 0.35 g (29%); yellow crystalline solid; mp 202–
203 °C.
1H NMR (500 MHz, CDCl3): δ = 7.28–7.37 (m, 3 H), 7.44–7.48 (m,
2 H), 7.51–7.59 (m, 5 H), 8.25 (s, 1 H), 9.56 (s, 1 H), 10.56 (s, 1 H),
12.70 (s, 1 H).
HRMS (EI): m/z calcd for C16H13NO4 [M+•]: 283.0845; found:
283.0833.
Anal. Calcd for C16H13NO4: C, 67.84; H, 4.63; N, 4.94. Found: C,
67.64; H, 4.62; N, 4.98.
13C NMR (125 MHz, CDCl3): δ = 113.1, 117.5, 117.7, 120.9, 127.3,
128.7, 129.0, 129.3, 129.9, 130.0, 130.2, 133.1, 136.8, 147.3, 158.0,
163.4, 188.0, 193.5.
HRMS (EI): m/z calcd for C22H14O4 [M+•]; 342.0892; found:
342.0880.
Acknowledgment
D.T.G., K.S., and M.T. would like to thank Foundation for Polish
Science (Grant number TEAM/2009-4/3). A.G.C. and G.Ch. thank
European Commission FP7 REGPOT-2008-1, Project BIOSOLE-
NUTI No 229927, Heraklitos grant from Ministry of Education and
GSRT.
Anal. Calcd for C22H14O4: C, 77.18; H, 4.12. Found: C, 76.96; H,
4.13.
6-Hydroxy-2,3-diphenyl-1-benzofuran-5,7-dicarbaldehyde (23)
Following the general procedure, phenol 9 (0.80 g, 2.8 mmol) was
treated with HMTA (1.00 g, 7.2 mmol) in TFA (10 mL). The result-
ing oil was initially recrystallized (CH2Cl2–hexanes), followed by
chromatography (SiO2, CH2Cl2) to afford pure aldehyde 23 as or-
ange crystals; yield: 144 mg (15%); mp 160–163 °C; Rf = 0.51
(CHCl3).
1H NMR (500 MHz, CDCl3): δ = 7.37 (m, 3 H), 7.49 (m, 3 H), 7.53
(m, 2 H), 7.68 (m, 2 H), 8.14 (s, 1 H), 10.37 (br s, 1 H), 10.72 (s, 1
H), 12.09 (s, 1 H).
13C NMR (125 MHz, CDCl3): δ = 107.7, 117.4, 120.1, 124.3, 126.8
(2 signals), 128.5 (2 signals), 128.7 (2 signals), 129.2 (2 signals),
129.4 (2 signals), 129.6 (2 signals), 130.8, 152.2, 157.6, 163.2,
190.1 (2 signals).
Supporting Information for this article is available online at
m
tgioSrantnugIifoop
r
itmnatr
References
(1) Jutz, C. Adv. Org. Chem. 1976, 9, 225.
(2) Gattermann, L.; Koch, J. A. Ber. Dtsch. Ges. Chem. 1897,
30, 1622.
(3) (a) Wynberg, H.; Meijer, E. W. Org. React. 1982, 28, 2.
(b) Wynberg, H. In Comprehensive Organic Synthesis; Vol.
2; Trost, B. M.; Fleming, I., Eds.; Pergamon Press: Oxford,
1991, 769–775.
(4) (a) Kantlehner, W. Eur. J. Org. Chem. 2003, 2530.
(b) Casiraghi, G.; Casnati, G.; Puglia, G.; Sartori, G.;
Terenghi, G. J. Chem. Soc., Perkin Trans. 1 1980, 1862.
HRMS (EI): m/z calcd for C22H14O4 [M+•]: 342.0892; found:
342.0899.
Synthesis 2012, 44, 3683–3687
© Georg Thieme Verlag Stuttgart · New York